New piece on the decision of #ERC to reverse their stricter rules after the community came together to voice our opinions - a great example of the power of collective action! Very happy to have been part of this - and to see how we can now build on this momentum 🙌 www.nature.com/articles/d41... 🧪

Reminder for the 51st Annual Meeting of the Scandinavian Society for Immunology! The meeting will take place September 7-10, 2026 in Bergen and includes a summer school program Early bird registration & abstract submission deadline: June 1st For full program and to register: www.ssi2026.no

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models - @mitkochinstitute.bsky.social go.nature.com/42td2fh

Excited to share recent work from our lab in @bloodjournal.bsky.social #BloodAdvances! We studied the impact of CD45-targeted radioimmunotherapy (RIT) on the bone marrow vascular niche. Turns out the vasculature is majorly disrupted by hematopoietic targeted RIT ☢️🩸 shorturl.at/qzWIB

📢 Tune in to this week's episode! Dr. Alfred Singer at the National Cancer Institute Center for Cancer Research discusses his pioneering work on thymus development and T cell differentiation, including how T cells are selected to become CD4 helper or CD8 cytotoxic cells. 🎧 https://bit.ly/4f2ci85

Marco et al. sought to expand the utility of immunizing radiation (IR) therapy by intratumorally delivering agents to remodel the tumor immune microenvironment (TIME). bit.ly/4t8ud0W

Chronic inflammation has long been linked to cancer, but how is that history retained in the tissue? In a new #Nature study, Nagaraja et al show that colitis leaves a lasting epigenetic memory in colonic stem cells, which persists after inflammation resolves & primes for subsequent tumor growth 🧪🔬

Thanks @the-node.bsky.social @biologists.bsky.social for allowing spreading the word @kawresearch.bsky.social @scilifelab.se @remeseiro-lab.bsky.social thenode.biologists.com/join-the-sum...

While TOX in CD8+ T cells is associated with exhaustion and poor prognosis, recent work by Naizir et al. showed the opposite effect in CD4+ T cells, where TOX expression was associated with TH1 differentiation, effector function, antitumor immunity, and autoimmune pathology. bit.ly/4rI2Vgt

We are seeking a highly motivated scientist with expertise in mouse embryo manipulation and the generation of genetically engineered mouse models. This is a permanent position with competitive compensation. Contact me via direct message if interested. Please share!

Looking for an awesome new PhD student, working at the intersection of #Virology and #Cancer research, looking to develop new therapies for #Glioma #Glioblastoma. Stipend, consumables and fees (UK/EU rates only) covered. #BeAVirusTinkerer #VITAL #TeamWAVU www.findaphd.com/phds/project...

I am really excited to share that our review on preclinical models of breast cancer metastasis is out in npj Breast Cancer! We provide a comprehensive overview of the major preclinical models used to study breast cancer metastasis www.nature.com/articles/s41...

Excited to share the final first-author paper of my PhD is online in Cancer Discovery @aacrjournals.bsky.social! doi.org/10.1158/2159... We identify an SPP1⁺ macrophage–IL-6–CRP inflammatory axis linked to resistance to checkpoint blockade in bladder cancer @bhardwajlab.bsky.social

This International Women's Day, we asked these award winners to name a woman who has had a positive impact on their career and wellbeing go.nature.com/4uawrOB

More leading voices for #DayofImmunology 2026🧬 Makoto Miyara (Sorbonne University / Pitié-Salpêtrière) will join our #DOI2026 webinar, bringing clinical insight on #RegulatoryTcells in transplantation and autoimmunity. 📅 April 29 at 15:00 Registration 🔗👇 @yefis-immunology.bsky.social

The 3 hardest things to learn as a scientist: 1. Trust the data.. especially when it’s not what you expected, 2. Trust the data.. allowing it to change your direction, 3. Trust the data.. but not too much: test with new data at every turn.

Excited to share our review "Pipe dream to Pipeline: Journey of cancer vaccines and the road ahead" that is now published in Cell Reports Medicine by Cell Press! (1/4)

Registration is now open and an all-in roster of immunologists anchor the premiere Dendritic cell meeting. www.dc2026sandiego.com/invited-spea... Sunny (blue state) San Diego. Sessions devoted to honoring 15 year anniversary of Nobel prize (Steinman) and translational advances…what is not to like.?

Too much data, too little thinking. A important essay from Ruslan Medzhitov on the importance of understanding data, not just generating it. A must read. @Yale www.nature.com/articles/s41...

Registration for the PALS Summer School in Transcriptomics is Open 🧬 23-26 June 2026 www.trippus.net/summerschool... Join us in this wonderful place 🇸🇪 to learn Theory & Computation from Famous Scientists in the Field w @remeseiro-lab.bsky.social Support by @scilifelab.se & @kawresearch.bsky.social

Registration is OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org

Understanding why cancers relapse - sometimes years or decades after successful treatment - is a major challenge in the cancer field This perspective in Nature discusses several of the important recent advances and new studies in the field of tumor dormancy 🧪⚕️ www.nature.com/articles/d41...

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity: Immunity www.cell.com/immunity/ful...

Please share and distribute ILC6 in Vancouver Abstract submission and registration are open: ilc6vancouver.com #immunosky #ILC6vancouver #ILC6 Lots of presenter spots available Secure your spot and discounted fees during early bird registration and come visit beautiful Vancouver.

@salva-iborra.bsky.social and Co in @jem.org elegantly sow that plasmacytoid DCs expand tissue-resident memory CD8+ T cell responses during viral reinfection rupress.org/jem/article/...

We're excited to host a distinguished lineup of speakers at @CellSymposia #CSHallmarks2026, including keynote speakers @johannajoyce.bsky.social & Faisal Mahmood @harvardmed.bsky.social. View the full speaker lineup: http://dlvr.it/TPbBqL

As the saying goes, one man’s trash is another man’s treasure: the flow-cytometry doublets that are routinely excluded from analysis are in fact a rich source of tumor-reactive T cells. #immunology #science #tumor #immunotherapy buff.ly/pETJPEH

ICYMI🚨 In light of the #NobelPrize recognizing discoveries in peripheral immune tolerance, our article "Regulatory T cells in the tumour microenvironment" is now free to read. Discover how #Tregs shape cancer immunity 📖 👇

Our #SITC25 recap is out today! Check out the standout presentations and insights from top institutions and speakers: bit.ly/3LLunuM#SITC25

How do world-leading scientists decide what makes it onto the EACR Congress stage? In our latest podcast episode, Johanna Joyce, Joana Paredes and Mariangela Russo talk about the impact of the Congress and their experiences on the Scientific Programme Committee. magazine.eacr.org/behind-the-s...

#WeekendRead! #EveryCellIsAnImmuneCell! Riedel, Mattavelli, Helal &co show @cp-immunity.bsky.social that fibroblasts in breast cancer metastatic lymph nodes sense tumor-derived TLR4 agonists to attract monocytes & form an immunosuppressive niche, favoring lung metastasis! dlvr.it/TPCYjz

..cross your 't's folks.. here's how! www.nature.com/articles/s41...

Online now: The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes

Wonderful news to start the week — our research on #immunotherapy and tissue-specific resistance mechanisms has been granted support from Cancerfonden! Stort tack till Cancerfonden och inte minst alla givare som gör detta möjligt! www.linkedin.com/posts/cancer...

Haven't read this one yet, but looks like a fantastic resource for everyone working with complex #spectral #flowcytometry panels!

One of the highlights of the annual SSI meeting is the recognition of researchers who have made significant contributions in the immunology field in Scandinavia. We want to extend our warmest congratulations to SWIMM member Chris Tibbitt @ki.se who was awarded the SSI Young Investigator Award 2025

CRATERs have been identified as sites of increased tumor antigen presentation where T cells can recognize and kill tumor cells bit.ly/3J8g42v  @ayaludin.bsky.social

Our new publication in @cp-immunity.bsky.social: Tertiary lymphoid structures with signs of functional adaptive immune responses in a subset of human gliomas. Association with longer overall patient survival and more immune-permissive tumor microenvironment. doi.org/10.1016/j.im...

📢📢FINAL CALL!! Closes tomorrow (Mon 20th Oct) Want a cool, blue skies project, integrating machine learning with virology to develop the medicines 💊of the future? Want to join a supportive team with an incredible culture? Apply now! 🧬🔬🧪🦠👨‍🔬👩‍🔬 www.findaphd.com/phds/project...

Our new review in @natbiomedeng.nature.com is out! RNA-loaded lipid nanoparticles (LNPs) have huge potential—but their strong liver and immune cell uptake has mostly confined them to vaccines and liver therapies. We explore how to move beyond those limits. free to read 🔗 rdcu.be/eLxGs

The #Scandinavian SSI #Immunology meeting has come to an end. Is has been 3 days full with amazing science from invited speakers, selected short talks, poster presentations, and social and network opportunities! We already look forward to the meeting in #Bergen! @ssi-immunology.bsky.social

1/2 Sharing exciting news! ✨ Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity! @cp-immunity.bsky.social

Check out our latest in @cp-trendscancer.bsky.social where rockstar PhD student @laurarosenberg.bsky.social reviews cancer therapies known to induce innate immune responses through the reactivation of Transposable Elements.

So happy to share that our review in #ImmunolRev is finally out! 😃 We discuss how the immune system builds specialized TLSs across organs and conditions. Huge thanks to @StephanGuillaume, @iannaconelab.bsky.social & @linterman.bsky.social for this collaboration! dx.doi.org/10.1111/imr.70063

📢 The deadline to register for the annual meeting of the #Scandinavian Society of #Immunology is approaching fast! Join us for a great line up of invited speakers, short talks, networking activities, etc in beautiful #Stockholm! More info below 👇🏼

The laboratory of Filipe Pereira @lunduniversity.bsky.social in @cp-immunity.bsky.social "uncover transcriptional circuits that control DC diversification" Very cool approach and can't wait to hear more about it the next French DC society meeting👇 www.cfcd.fr/meeting/prog...

The registration deadline for the upcoming SSI 2025 meeting in Stockholm is coming up quickly! Register before the 12th of September 23:59 to attend the conference. The preliminary program has been published, so take a look on our website if you're curious: swimm.se/ssi2025-scie...

Can't get enough of #immunology? Join Global ImmunoTalks — a free, international webinar series featuring leading immunologists from around the world 🌍 🔬 Weekly talks 📅 Live & recorded sessions 🌐 Open to everyone Follow @globalimmuno.bsky.social for the latest updates! Starting today 👇🏼

Dendritic cells! What can’t they do?! In addition to being the surveilling determinants of self vs. non-self, they can degrade NETs, unmasking tumors protected by suppressive neutrophils. www.sciencedirect.com/science/arti...

Thrilled to share our new publication on the first-in-human phase 1 trial of intratumoral Fc-engineered CD40 agonistic antibody 2141-V11 in metastatic cancer. Over 10 years of preclinical work at the Ravetch lab led to this moment, made possible by an amazing team! 🧵 🪡 www.cell.com/cancer-cell/...